Merck Animal Health Receives the US FDA’s Approval for Bravecto (fluralaner) Monthly Chews to Protect Dogs and Puppies Against Fleas and Ticks

Shots:

• The US FDA approves Bravecto 1-month (fluralaner) chews for dogs and puppies aged≥ 8 weeks. The approval will expand Merck’s parasiticide portfolio, which are extended duration flea and tick protection products offering parasite protection for dogs
• The product is suitable for dogs in the early stages of life to begin a regimen of monthly flea and tick protection
• Bravecto 1-month is administered as a single, monthly flavored chew formulation for treatment and prevention of fleas and treatment and control of ticks and is expected to be available in the coming months

Click here ­to­ read full press release/ article | Ref: Merck Animal Health | Image: Merck and Chewy